Troy, VA—Kerry will lead the sales, marketing, and distribution of Bio-Cat, Inc.’s proprietary probiotic strain OPTI-BIOME MB40, according to a press release from Bio-Cat.
OPTI-BIOME MB40, Bacillus subtilis ATCC122264, is a stable, non-GMO probiotic strain that was shown in a 2019 peer-reviewed study to help support gastrointestinal health.
A press release from Bio-Cat notes that Kerry has shown past success marketing probiotics, placing its GanedenBC30 probiotic in over 1,000 food and beverage products worldwide. Bio-Cat CEO Chris Schuler hopes to see similar success with MB40: “Given the impressive performance of the MB40 strain and its potential to have a significant impact on the dietary supplement, functional food and beverage, and companion animal industries, we have decided to work with a partner who will help scale MB40 globally. Kerry’s expertise, commitment to develop a leading probiotic platform, access to global resources, and plans to further scientifically support MB40 make them an ideal partner.”
As part of the agreement, Kerry will refresh the MB40 brand over the next few months. The new brand name, once fully developed, will be supported by Kerry’s global marketing and commercial infrastructure.
John Quilter, VP & General Manager of Kerry’s ProActive Health business, said in the press release: “We are delighted to partner with Bio-Cat to further develop and market this unique and highly-stable Bacillus strain, which will complement our growing portfolio of science-backed branded ingredients in our ProActive Health portfolio.”